During the past decade, Advanced Medical Research Center conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 21 clinical trials were completed, i.e. on average, 72.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 13 clinical trials were completed. i.e. 108.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Medical Research Center" #1 sponsor was "Celgene" with 9 trials, followed by "Pfizer" with 8 trials sponsored, "Gilead Sciences" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored and "Arena Pharmaceuticals" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Medical Research Center" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Centocor, Inc." with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Medical Research Center" are "Ulcerative Colitis" (14 trials), "Crohn Disease" (7 trials), "Crohn's Disease" (3 trials), "Eosinophilic Esophagitis" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Advanced Medical Research Center" in a lesser frequency.

Most popular intervention types in "Advanced Medical Research Center" are "Drug" (38 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Etrasimod" (5 trials), "Filgotinib" (4 trials), "GED-0301" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Medical Research Center" are 40 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Medical Research Center". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 22 completed trials in Advanced Medical Research Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Medical Research Center, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".